Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
New Ray Medicine International Holding Ltd. ( (HK:6108) ) has shared an announcement.
New Ray Medicine International Holding Ltd. has announced a proposed capital reorganization involving share consolidation, capital reduction, and share sub-division. This reorganization aims to consolidate every ten existing shares into one, reduce the par value of shares, and subsequently sub-divide authorized but unissued shares. The reorganization is subject to shareholder approval at a special general meeting, and it may impact the company’s financial structure and shareholder equity.
More about New Ray Medicine International Holding Ltd.
New Ray Medicine International Holding Ltd. is a company incorporated in Bermuda with limited liability, operating in the pharmaceutical industry. The company is listed on the Hong Kong Stock Exchange and is involved in the production and distribution of pharmaceutical products.
Average Trading Volume: 3,037,373
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$66.87M
For an in-depth examination of 6108 stock, go to TipRanks’ Stock Analysis page.